Desheva Yulia, Sergeeva Maria, Kudar Polina, Rekstin Andrey, Romanovskaya-Romanko Ekaterina, Krivitskaya Vera, Kudria Kira, Bazhenova Ekaterina, Stepanova Ekaterina, Krylova Evelina, Kurpiaeva Maria, Lioznov Dmitry, Stukova Marina, Kiseleva Irina
FSBSI 'Institute of Experimental Medicine', 197022 Saint Petersburg, Russia.
Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia.
Vaccines (Basel). 2024 Nov 27;12(12):1334. doi: 10.3390/vaccines12121334.
BACKGROUND/OBJECTIVES: Humoral immunity directed against neuraminidase (NA) of the influenza virus may soften the severity of infection caused by new antigenic variants of the influenza viruses. Evaluation of NA-inhibiting (NI) antibodies in combination with antibodies to hemagglutinin (HA) may enhance research on the antibody response to influenza vaccines.
The study examined 64 pairs of serum samples from patients vaccinated with seasonal inactivated trivalent influenza vaccines (IIVs) in 2018 according to the formula recommended by the World Health Organization (WHO) for the 2018-2019 flu season. Antibodies against drift influenza viruses A/Guangdong-Maonan/SWL1536/2019(H1N1)pdm09 and A/Brisbane/34/2018(H3N2) were studied before vaccination and 21 days after vaccination. To assess NI antibodies, we used an enzyme-linked lectin assay (ELLA) with pairs of reassortant viruses A/H6N1 and A/H6N2. Anti-HA antibodies were detected using a hemagglutination inhibition (HI) test. The microneutralization (MN) test was performed in the MDCK cell line using viruses A/H6N1 and A/H6N2.
Seasonal IIVs induce a significant immune response of NI antibodies against influenza A/H1N1pdm09 and A/H3N2 viruses. A significantly reduced 'herd' immunity to drift influenza A/H1N1pdm09 and A/H3N2 viruses was shown, compared with previously circulating strains. This reduction was most pronounced in strains possessing neuraminidase N2. Seasonal IIVs caused an increase in antibodies against homologous and drifted viruses; however, an increase in antibodies to drifting viruses was observed more often among older patients. The level of NI antibodies for later A/H1N1pdm09 virus in response to IIVs was statistically significantly lower among younger people. After IIV vaccination, the percentage of individuals with HI antibody levels ≥ 1:40 and NI antibody levels ≥ 1:20 was 32.8% for drift A/H1N1pdm09 virus and 17.2% for drift A/H3N2 virus. Antisera containing HI and NI antibodies exhibited neutralizing properties in vitro against viruses with unrelated HA of the H6 subtype.
Drift A/H1N1pdm09 and A/H3N2 viruses demonstrated significantly lower reactivity to HI and NI antibodies against early influenza viruses. In response to seasonal IIVs, the level of seroprotection has increased, including against drift influenza A viruses, but protective antibody levels against A/H1N1pdm09 have risen to a greater extent. A reduced immune response to the N1 protein of the A/H1N1pdm09 drift virus was obtained in individuals under 60 years of age. Based on our findings, it is hypothesized that in the cases of a HA mismatch, vaccination against N1-containing influenza viruses may be necessary for individuals under 60, while broader population-level vaccination against N2-containing viruses may be required.
背景/目的:针对流感病毒神经氨酸酶(NA)的体液免疫可能会减轻由流感病毒新抗原变体引起的感染严重程度。评估NA抑制(NI)抗体与血凝素(HA)抗体相结合,可能会加强对流感疫苗抗体反应的研究。
该研究根据世界卫生组织(WHO)针对2018 - 2019流感季节推荐的公式,检测了2018年接种季节性三价灭活流感疫苗(IIV)的64对患者血清样本。在接种疫苗前和接种疫苗21天后,研究了针对漂移流感病毒A/广东 - 茂南/SWL1536/2019(H1N1)pdm09和A/布里斯班/34/2018(H3N2)的抗体。为了评估NI抗体,我们使用了重组病毒A/H6N1和A/H6N2对的酶联凝集试验(ELLA)。使用血凝抑制(HI)试验检测抗HA抗体。在MDCK细胞系中使用病毒A/H6N1和A/H6N2进行微量中和(MN)试验。
季节性IIV可诱导针对甲型流感H1N1pdm09和H3N2病毒的NI抗体产生显著免疫反应。与先前流行的毒株相比,对漂移甲型流感H1N1pdm09和H3N2病毒的“群体”免疫力显著降低。这种降低在具有神经氨酸酶N2的毒株中最为明显。季节性IIV导致针对同源和漂移病毒的抗体增加;然而,在老年患者中更常观察到针对漂移病毒的抗体增加。在年轻人中,针对后期甲型流感H1N1pdm09病毒的NI抗体水平在统计学上显著低于老年人。接种IIV后,HI抗体水平≥1:40且NI抗体水平≥1:20的个体百分比,对于漂移甲型流感H1N1pdm09病毒为32.8%,对于漂移甲型流感H3N2病毒为17.2%。含有HI和NI抗体的抗血清在体外对具有H6亚型不相关HA的病毒具有中和特性。
漂移甲型流感H1N1pdm09和H3N2病毒对针对早期流感病毒的HI和NI抗体反应显著降低。针对季节性IIV,血清保护水平有所提高,包括针对漂移甲型流感病毒,但针对甲型流感H1N1pdm09的保护性抗体水平上升幅度更大。60岁以下个体对甲型流感H1N1pdm09漂移病毒的N1蛋白免疫反应降低。根据我们的研究结果,推测在HA不匹配的情况下,60岁以下个体可能需要接种针对含N1流感病毒的疫苗,而可能需要对更广泛的人群接种针对含N2病毒的疫苗。